TY - JOUR
T1 - Predictors of Follow-Up Visits Post Radical Prostatectomy
AU - Khan, Saira
AU - Hicks, Veronica
AU - Rancilio, Danielle
AU - Langston, Marvin
AU - Richardson, Katina
AU - Drake, Bettina F.
N1 - Funding Information:
The authors would like to thank the participants of the Washington University Prostate Cancer Prospective Cohort (PCPC) for their important contributions. The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This project was supported, in part, by funds from the St. Louis Men’s Group Against Cancer. Drs. Khan and Langston were supported by T32190194 (Colditz). Dr. Drake was supported by 1U54CA153460-01. Drs. Khan, Langston, and Drake were also supported by the foundation for Barnes Jewish Hospital and by Siteman Cancer Center. This content is solely the responsibility of the authors and does not necessarily represent the official view of the National Institutes of Health.
Funding Information:
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This project was supported, in part, by funds from the St. Louis Men’s Group Against Cancer. Drs. Khan and Langston were supported by T32190194 (Colditz). Dr. Drake was supported by 1U54CA153460-01. Drs. Khan, Langston, and Drake were also supported by the foundation for Barnes Jewish Hospital and by Siteman Cancer Center. This content is solely the responsibility of the authors and does not necessarily represent the official view of the National Institutes of Health.
Publisher Copyright:
© 2018, The Author(s) 2018.
PY - 2018/7/1
Y1 - 2018/7/1
N2 - Long-term follow-up care among prostate cancer patients is important as biochemical recurrence can occur many years after diagnosis, with 20%–30% of men experiencing biochemical recurrence within 10 years of treatment. This study examined predictors of follow-up care among 1,158 radical prostatectomy patients, treated at the Washington University in St. Louis, within 6 months, 1 year, and 2 years post surgery. Predictors examined included age at surgery, race (Black vs. White), rural/urban status, education, marital status, and prostate cancer aggressiveness. Multivariable logistic regression was used to assess the association between the predictors and follow-up visits with a urologist in 6 months, the 1st year, and the 2nd year post surgery. In a secondary analysis, any follow-up visit with a prostate-specific antigen (PSA) test was included, regardless of provider type. Men that were Black (6 months OR: 0.60; 95% CI [0.36, 0.99], 1 year OR: 0.34; 95% CI [0.20, 0.59], 2 year OR: 0.41; 95% CI [0.25, 0.68]), resided in a rural residence (1 year OR: 0.61; 95% CI [0.44, 0.85], 2 year OR: 0.41; 95% CI [0.25, 0.68]), or were unmarried (2 year OR: 0.69; 95% CI [0.49, 0.97]) had a reduced odds of follow-up visits with a urologist. In models where any follow-up visit with a PSA test was examined, race remained a significant predictor of follow-up. The results indicate that Black men, men residing in a rural residence, and unmarried men may not receive adequate long-term follow-up care following radical prostatectomy. These men represent a high-risk group that could benefit from increased support post treatment.
AB - Long-term follow-up care among prostate cancer patients is important as biochemical recurrence can occur many years after diagnosis, with 20%–30% of men experiencing biochemical recurrence within 10 years of treatment. This study examined predictors of follow-up care among 1,158 radical prostatectomy patients, treated at the Washington University in St. Louis, within 6 months, 1 year, and 2 years post surgery. Predictors examined included age at surgery, race (Black vs. White), rural/urban status, education, marital status, and prostate cancer aggressiveness. Multivariable logistic regression was used to assess the association between the predictors and follow-up visits with a urologist in 6 months, the 1st year, and the 2nd year post surgery. In a secondary analysis, any follow-up visit with a prostate-specific antigen (PSA) test was included, regardless of provider type. Men that were Black (6 months OR: 0.60; 95% CI [0.36, 0.99], 1 year OR: 0.34; 95% CI [0.20, 0.59], 2 year OR: 0.41; 95% CI [0.25, 0.68]), resided in a rural residence (1 year OR: 0.61; 95% CI [0.44, 0.85], 2 year OR: 0.41; 95% CI [0.25, 0.68]), or were unmarried (2 year OR: 0.69; 95% CI [0.49, 0.97]) had a reduced odds of follow-up visits with a urologist. In models where any follow-up visit with a PSA test was examined, race remained a significant predictor of follow-up. The results indicate that Black men, men residing in a rural residence, and unmarried men may not receive adequate long-term follow-up care following radical prostatectomy. These men represent a high-risk group that could benefit from increased support post treatment.
KW - Black men
KW - follow-up
KW - prostate cancer
KW - radical prostatectomy
KW - survivors
UR - http://www.scopus.com/inward/record.url?scp=85048983245&partnerID=8YFLogxK
U2 - 10.1177/1557988318762633
DO - 10.1177/1557988318762633
M3 - Article
C2 - 29540091
AN - SCOPUS:85048983245
VL - 12
SP - 760
EP - 765
JO - American Journal of Men's Health
JF - American Journal of Men's Health
SN - 1557-9883
IS - 4
ER -